2020 Vol.22 No.1 English
目次
English
■FEATURE PAPERS: THE PRESENT AND FUTURE TREATMENT
Support for Patients with Difficult Treatment
K. IKEDA 1
Novel Anti-HIV Drugs under Development
K. MAEDA 7
Trends and Current Status of Antiretroviral Therapy
K. TSUKADA 13
■REVIEW (CONTRIBUTION)
＜Social＞
What Is Undetectable = Untransmittable (U = U) ?: The Logic behind Zero Risk of Infection
T. OKITA, Y. INOUE, M. YAMAGUCHI, T. SHIRASAKA 19
■ORIGINAL RESEARCH REPORT
＜Clinical＞
Association between Plasma Pentraxin 3 Levels and Lifestyle Related Diseases in HIV Infected Individuals
R. MINAMI, S. TAKAHAMA, K. KOYAMA, M. KOMATSU, M. JOZAKI, Y. NAGAYO, S. INUMARU, M. YAMAMOTO 28
■CASE REPORT
＜Clinical＞
Successful Management of Hodgkin Lymphoma in Patient with Hemophilia B and HIV Infection
C. NAITO, K. YANAGISAWA, Y. OGAWA, Y. ISHIZAKI, T. MASHIMO, Y. SHIROTA, A. NAKAMURA, F. GOHDA, H. UCHIUMI, N. TSUKAMOTO, H. HANDA 36
■NOTES
＜Social＞
A Difficulty of Getting Public Expenditure System for a HIV Vertical Infected Student Studying Abroad in Japan
Y. SEKI, M. NAKAJIMA 42
＜Clinical＞
Educational Program for General Physicians to Promote Early Diagnosis and Initiation of Treatment of Human Immunodeficiency Virus Infection
H. TAKAHASHI, Y. YOKOMAKU, K. TSUKADA, F. OTSUKA, H. MORITA, T. NAITO 46
＜Pharmaceutical＞
Investigation of Drug Interaction Based on CYP Inhibitory Effect between Anti-Retrovirus Therapeutic Agents and Glucocorticoids
T. MINE, T. MURO, Y. KODAMA, T. NAKAMURA, H. SASAKI 51